Explore more publications!

New Updates on Biostimulant Market, SBM’s and Pheromones: 7th BioEx Summit

Manel Cervera, DunhamTrimmer Managing Partner and Chief Commercial Officer

Manel Cervera, DunhamTrimmer Managing Partner and Chief Commercial Officer

Event taking place March 12–13 in Shanghai, China, will provide deep insights from the industry's frontlines

For the first time, growth projections fall just below double-digits. But make no mistake — the market is adding over $650 million per year in new value by 2030: A mature growth story, not declining”
— Manel Cervera, DunhamTrimmer Managing Partner and Chief Commercial Officer
SHANGHAI, CHINA, March 12, 2026 /EINPresswire.com/ -- DunhamTrimmer Managing Partner and Chief Commercial Officer Manel Cervera will speak at the 7th BioEx Summit (Biopesticides, Biostimulants and Biofertilizers) taking place March 12–13 in Shanghai, one of the leading international forums dedicated to agricultural biologicals.

During his presentation, Cervera will share updated market intelligence from DunhamTrimmer’s latest global research, including developments in the biostimulant market, Single Biostimulant Molecules (SBMs), and the expanding role of pheromone-based technologies in large-scale crop systems.

The session will explore regional market dynamics across the United States, Brazil, China, and Europe, highlighting the strategic implications for manufacturers, distributors, and investors in the rapidly evolving biological inputs sector.

More details about the event and presentation are available in the AgroPages announcement:
https://news.agropages.com/News/NewsDetail---56855.htm

LEONARDO GOTTEMS DO SANTOS
MKT Place
+39 320 232 0023
email us here
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions